Staph, Sepsis, MRSA Flashcards

1
Q

Colony appearance by Coag+/- staph

A

S. aureus= gold beta hemolytic

Coag (-) = small white nonhemolytic colonies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

___% of healthy people may be _____or _____ colonized with S. aureus

A

25%

persistently or transiently

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Colonization rate of S. aureus is higher among…(4)

A

IDDM

HIV

Hemodialysis

Skin Damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diseases with increased risk for S. aureus infection (4)

A
  1. DM
  2. PMN defect/deficiency (neutropenia,CGD, Jobs, Chediak-Higashi)
  3. Skin abnormalities
  4. Prosthetic devices
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Most MRSA infect

A

Skin and soft tissue

*5-10% have been invasive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pyogenic bacterium causes ___ at ___ or ____ sites

A

abscess

primary or distant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cells that infultrate after inflammatory response

A

first PMN

then MQ and FB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Staph vs strep on skin

A

Strep = rapidly producing cellulitis

Staph = Purulent foci

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

___ is alright for MSSA, but not MRSA

A

Bactrim

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Staph produces what three toxins

A
  1. Cytotoxins
  2. Pyrogenic Superantigen toxins
    1. Foodborne (Enterotoxin)
    2. Staphylococcal TSSS (TSST1)
  3. Exfoliative toxin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

TSST1 produced at …

A

site of colonization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

antistaph antibodies efficacy?

A

Not shown to be protective in vivo. No vaccine available.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Exfoliative toxin mediates…

A

SSSS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

For Staph toxins, you want to use ABs that do what?

A

halt protein synthesis

(e.g. Clindamycin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Clinical manifestations - skin and soft tissue infection (6)

A
  1. Impetigo
  2. Folliculitis
  3. Furuncle/carbuncle, abscess
  4. Hidradentitis suppurativa (intertriginous)
  5. Cellulitis/erysipelas/Fasciitis
  6. Pyomyositis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

General clinical manifestations of staph (9)

A
  1. Skin and soft tissue infections
  2. Bacteremia
  3. CV infection
  4. Sepsis and TSS
  5. Splenic abscess
  6. Bone and Joint infection
  7. Pulmonary infection
  8. Meningitis
  9. Bacteruria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

S. aureus meningitis most commonly occurs in the setting of…

A

in setting of head trauma or neurosurgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Blood cultures: never order…

A

just one. (always two)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Three catergories of staph infections

A
  1. Healthcare-associated (nosocomial)
  2. Community acquired
  3. Healthcare associated community onset (long-term care facilities)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Risk factors for bacteremia (4)

A

IV catheters

MRSA colonization

Implants/prosthetic devices

IV drug use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Staph Sx - bone and joint pain

A

Vertebral osteomyelitis

Discitis

Epidural abscess

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Staph bacteremia Sx - Protracted fever/sweats

A

endocarditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

LUQ pain in staph bacteremia

A

Splenic infarction, abscess

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Staph bacteremia Sx - CVA tenderness

A

Renal infarction

psoas abscess

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Staph bacteremia Sx - Headache

A

Septic embolus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Staph Aureus physical exam should look for what 3 things?

A

Cardiac exam for new murmurs or evidence of HF

Stigmata of endocarditis

neurological exam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What are the stigmata of endocarditis

A

Roth spots = retinal hemorrhages with pale centers

Osler’s nodes = Painful immunologic lesions on hands/feet

Janeway’s lesions = Non-tender, non immunologic lesions (hands/feet)

(also petechiae, splenomegaly, murmur, clubbing, fever)

28
Q

Treatment of Staph aureus bacteremia may include ____ depending on sensitivity results

A

Empiric antibiotics

29
Q

DOC for empiric treatment of SA bacteremia

A

Vm

(toxicity is concern)

30
Q

Consider _____ or ______ for MSSA

A

Nafcillin/oxacillin

or cephazolin

31
Q

Followup blood cultures ___ after initiating therapy to demonstrate clearance

A

48-72 hours

(should be daily)

32
Q

Duration of therapy for uncomplicated infection (abscence of cardiac abnormalities)

A

14 days of IV therapy

33
Q

Penicillinase resistant Pens

A

Nafcillin

Oxacillin

34
Q

_______ related infections present special management problems

A

Central IV catheters

35
Q

Enterococcus is resistant stuff. What do you use to treat?

A

Vm, Pen, Linezolid

(ceph, macrolides, fluoroquinolone = NO)

36
Q

In sepsis, signs occur…

A

in tissues remote from the site of infection

37
Q

SIRS =

A

clinical syndrome complicating a noninfectious insult

(–> pancreatitis, pulmonary contusion)

38
Q

Sepsis Step

A

2 SIRS

*and*

Confirmed or suspected infection

39
Q

Step for Severe sepsis

A
  • Sepsis + Signs of end organ damage
  • Hypotension
  • Lactate >4mmol
40
Q

Step for Septic Shock

A
  • Severe sepsis + signs of end organ damage

*and*

  • PERSISTENT hypotension
  • Lactate >4mmol
41
Q

Septic Shock =

A

Sepsis-induced HoTN persisting despite fluid resuscitation

42
Q

Septic shock is a _____ shock

A

Vasodilatory

43
Q

Sepsis risk factors

A
  • ICU with nosocomial
  • Bacteremia
  • >65
  • IC patients
  • IDDM
  • Cancer
  • CA-PNA
  • Genetic stuff
44
Q

Incidence of sepsis is greatest among…

A

African american males >65 in winter

45
Q

Sepsis is more frequently caused by gram __ organisms

A

positive

46
Q

Four steps in clincial eval of Septic patient

A
  1. Determine source
  2. Assess respiratory status
  3. assess perfusion
  4. assess end organ effects (lactate,renal/hepatic fxn)
47
Q

Ways to evaluate LRT-associated sepsis

A
  • Sputum
  • Rapid influenza test
  • Urinary antigen testing (pneumococcus, legionella)
  • Bronchiolar lavage
48
Q

General early management of sepsis (3)

A

Airway control

Venous access

Maintain perfusion

49
Q

Control of septic focus by ___ or _______

A

early ABs

Possible debridement/surgery

50
Q

Vasoactive agents in septic shock

Which are dilatory?

A

Dobutamine**

DA/EPI/NE

Phenylephrine

Amrinone**

51
Q

Phenylephrine has no effect on ___ or _____

A

heart rate or contractility

52
Q

Sepsis mortality estimate

A

10-50%

53
Q

Methicillin resistance is mediated by

A

PBP-2a

encoded by the mecA gene

54
Q

mecA gene is located on a ______

A

mobile genetic element

Staph chromosomal cassette= SCCmec

55
Q

HA-MRSA occurs __ after hospitalization or within ____ of exposure to healthcare

A

48 hrs

12months

56
Q

HA-MRSA is the leading cause of

A

Surgical site infections

57
Q

HA MRSA electrophoresis pattern

A

USA100

USA200

58
Q

CA-MRSA is associated with _____ infections

A

skin and soft tissue infections in healthy young persons

59
Q

CA-MRSA electrophoresis pattern

A

USA300 or USA400

60
Q

ABs that may have played a role in development of MRSA

A

Ceph

FQ

61
Q

In both examples of AB resistance spread (human and animal),the resistent bacteria develop within ____

A

the GIT

62
Q

The association of antimicrobial drugs and MRSA was stronger for persons who had recieved…

A

more Rx’s ofany class of antimicrobials

63
Q

Community acquired or health care associated greater?

A

HCA

64
Q

MRSA increased drastically (2k–368k) from…

A

1993 to 2005

65
Q

Key interventions for prevention of MRSA (4)

A
  • Hand hygeine
  • Decontamination
  • Contact precautions
  • Active surveillance cultures (ASCs)
66
Q

Next threat on the horizon

A

VRSA

67
Q

Major Vm issue

A

ototoxicity